NASDAQInformation TechnologyEngineering & ConstructionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SUNE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve from loss-making to positive free cash flow | A primary condition in SUNATION ENERGY INC's published investment case. The stated target is Free cash flow yield improves from -12% to positive. | Broken | Free cash flow yield remains negative beyond next 4 quarters | Valuation inputs unavailable A completed valuation measurement is required. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making small-cap business with a strategic growth angle, rather than an established durable compounder. The thesis is on watch: recent performance is below its industry cohort, although it has not freshly broken.
The evidence points to SUNE being cheap versus peers, while the model has low confidence and the expectations gap is slightly negative. That suggests modest expectations, but the valuation signal is uncertain and does not remove the risks of losses or volatile management.
Near term, financial performance is rated neutral, with a 35% estimated chance of a miss and a record of erratic earnings surprises. Management has made progress on reducing liabilities and growing commercial and service revenue, but the planned Suniva merger still needs to close, and a new financial obligation adds a capital-allocation concern.
Over the next year, execution hinges on closing the Suniva merger, sustaining growth beyond residential solar, and preserving liquidity. A guidance cut would be a meaningful negative; lower interest rates and steadier results from large technology companies are listed as possible sector tailwinds, though they do not resolve SUNE’s company-specific risks.
For a 1 to 3 year view, SUNE offers a potentially broader solar business, but the evidence remains mixed and the thesis depends on execution amid losses and high risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Sunation aims to grow revenue to about $67.5 million in 2025. |
| Intact |
| Revenue falls below $65 million in FY25 |
Revenue: $8.162M FY2026-Q2; GAAP. Published target: ~67.5 USD_MILLIONS. Annual target cannot be compared with a quarterly or TTM observation. Aug 12, 20268,161,987 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete and integrate Suniva acquisition | The company completed the Suniva acquisition to boost growth. | Improving | Acquisition integration fails or is delayed beyond 2026 Q2 | Merger signed 2026-06-05, amended 2026-09-04; target 2026-06-30 SUNE signed Suniva merger in June 2026 and amended it in September 2026. No signs of integration failure or delay. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.